Nurtec ODT 75 MG tablet 8S
Ended Awarded Last action
- Contract number
- SPE2DR26FA2Y4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,405
Award facts
- Contract value 100% obligated
- $22,404.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on January 20, 2026, for NURTEC ODT 75 mg tablets (8-count) valued at $22,404.70. This firm fixed-price contract, with a completion date of January 21, 2026, was funded by the Defense Logistics Agency (DLA) and represents a non-set-aside, competitively awarded order. The award falls under AmerisourceBergen's parent company, Cencora, Inc. (doing business as AmerisourceBergen), which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031. This prime IDC serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
NURTEC ODT is a migraine treatment medication, reflecting the Defense Health Agency's ongoing procurement of specialized pharmaceuticals to support military treatment facilities and personnel. The delivery order structure and firm fixed pricing are typical for DLA pharmaceutical acquisitions under the broader pharmaceutical supply chain, where AmerisourceBergen maintains a critical role as a preferred vendor. The expedited completion timeline (one day) indicates an urgent resupply need for this particular medication within the federal military healthcare system.
Quick answers
Who was awarded contract SPE2DR26FA2Y4?
SPE2DR26FA2Y4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FA2Y4 worth?
The government has obligated $22,405 on SPE2DR26FA2Y4.
Is contract SPE2DR26FA2Y4 an order under another contract?
Yes. SPE2DR26FA2Y4 is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FA2Y4 competed?
The extent of competition for SPE2DR26FA2Y4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award